INTRODUCTION
Artemisia anomala S. Moore is a perennial herb in the family Compositae [1] . In Chinese medicine, it has traditionally been used as an analgesic, antibiotic, and wound-curing agent. Chemical analysis has revealed that their tissues are rich in phenolic compounds and others also are biologically active [2] . Recent studies confirm that extracts of A. anomala have antibacterial and antioxidant properties. These extracts are promising drugs available for bacterial or inflammatory diseases treatment [1] and may serve as a novel therapeutic strategy.
Psoriasis is a chronic inflammatory dermatopathy that affects 1 -3 % of individuals worldwide [3] [4] [5] [6] [7] [8] . Typically, psoriasis patients have well-defined scaly, erythematous patches on the skin, which can seriously reduce the quality of life of afflicted patients [9, 10] . The key physiological mechanism of psoriasis is the activation of the innate and adaptive immune systems, causing rapid division and differentiation of epidermal keratinocytes, generating hyperplasia finally [11] . Given the potential therapeutic role of extracts of A. anomala in inflammation, its effect on psoriasis is of interest. Xiong et al. showed that the viability of human keratinocytes was enhanced during the treatment of psoriasis [12] . Thus, the keratinocyte viability may be a key index of psoriasis. However, the effect of A. anomala extract on keratinocyte viability remains unknown.
The present study was undertaken to determine the effect of A. anomala extracts on cell viability and apoptosis of keratinocytes, as well as the antioxidant properties of keratinocytes treated with these extracts. In this study, A. anomala extracts may have potential as therapy for psoriasis. They may modulate the mitogenactivated protein kinase (MAPK) and caspase signaling pathways.
EXPERIMENTAL

Cell culture
The keratinocyte cell line HaCaT (American Type Culture Collection, Manassas, VA, USA) was used. It was maintained in Dulbecco's modified Eagle's medium (DMEM; Gibco, Invitrogen, Paisley, UK) supplemented with 1.4 mM Lglutamine, antibiotics (100 IU/mL penicillin and 100 μg/mL streptomycin), and 10 % fetal bovine serum (FBS; Gibco, Invitrogen, Paisley, UK). Cells were cultured in a humidified incubator at 37 °C with a 5 % CO 2 atmosphere for 2 days until they reached 70 -80 % confluency, and then were photographed with a phase contrast microscopy (Olympus Optical Co., Tokyo, Japan).
Plant material and A. anomala extracts
A. anomala material was acquired from Ruixing Drugstore (Hangzhou, China) as the Chinese herbal medicine. A total of 400 kg dried aerial parts were chopped, suspended in acetone: (15:1), and sonicated with ultrasound for 30 min to yield the extracts.
The flavonoid content of the extracts was assessed with NaNO 2 -Al(NO 3 ) 3 colorimetry, using an ultraviolet spectrophotometer [13] . The flavonoid content of a water extract was calculated, and was normalized to the level of the plant flavonoid pigment, rutin. The flavonoid content of A. anomala extracts (3.1 μg/mL) was higher than the other plant tissues.
A. anomala extract treatment
The effect of the extract on the HaCaT keratinocytes in media (DMEM) was evaluated. For this experiment, HaCaT cells were incubated in A. anomala extract for 12 h or24 h, respectively. The control group cells were incubated in DMEM without the extract.
The effect of A. anomala extract on MAPK signaling pathway was also examined. Cells received the MAPK signaling pathway activator anisomycin at 10 µM.
Cell viability assay
The viability of HaCaT cells treated with different extracts was assessed with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay [14] . HaCaT cells (5×10 
Reactive oxygen species (ROS) assay
The ROS content in HaCaT cells treated with different extracts was quantified by an OxiSelect ROS assay kit (Cell Biolabs Inc, San Diego, CA, USA). HaCaT cells (1×10 5 cells/well) were inoculated in 6-well culture plates, washed three times with cold phosphate buffered saline (PBS), and co-incubated with 100 μL of 2, 7-dichlorofluorescein diacetate (DCFH-DA; Shanghai, China) for 45 min. Then, samples were collected by a trypsin digestion approach, centrifuged, and re-suspended in PBS. ROS level was analyzed on a flow cytometer (Cytomics FC 500; Beckman Coulter, USA).
Apoptosis assay
Apoptosis was quantified with an Annexin V-FITC/PI apoptosis detection kit (Invitrogen, USA). Keratinocytes treated with different extracts were placed in 6-well culture plates, fixed with 2% paraformaldehyde, washed with cold PBS, and re-suspended in 100 μL annexin-binding buffer. At this point, cell counting was carried out. Apoptotic HaCaT cells were assessed by flow cytometry, based on the manufacturer's protocol.
Quantitative reverse-transcription polymerase chain reaction (qRT-PCR)
When the cultured HaCaT keratinocytes had reached 70-80 % confluency, total RNA in the cells that had received different extract treatments was extracted with TRIzol reagent (Life Technologies, USA), according to the manufacturer protocol. Reverse transcription was performed with the RevertAid First Strand cDNA Synthesis Kit (Fermentas, USA) using 2 μg of RNA. qRT-PCR for c-Jun N-terminal kinase (JNK), extracellular regulated protein kinase (ERK), and MAPK was carried out via FastStart Universal SYBR Green Master (Roche Diagnostics, Tokyo, Japan). The amplification parameters were: 10 min at 25 °C, 30 min at 48 °C, and a final step of 5 min at 95 °C.
Western blot
Standard western blotting was carried out for the protein expression assay from HaCaT cells treated with different extracts. In brief, cells were washed two or three times with cold PBS, and the proteins were isolated with 10-times radioimmunoprecipitation assay (RIPA) lysis buffer containing protease inhibitors (Biomiga Inc., San Diego, CA, USA). Then the proteins were evaluated with the bicinchoninic acid (BCA) protein assay kit (Pierce; Rockford, USA). Primary antibodies to c-Jun N-terminal kinase (ab124956; 1:1,000), ERK (ab196883; 1:1,000), MAPK (ab197348; 1:1,000), caspase-9 (ab32539), caspase-8 (ab25901), caspase-3 (ab2171), Bcl-2 (ab32124), B-cell lymphoma-2 associated X (Bax; ab32503), and the internal control glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were from Abcam (Cambridge, United Kingdom). Thereafter, secondary antibodies (1:1,000) were marked by horseradish peroxidase for 2 h at 37 °C. Samples were dissolved on a polyvinylidene fluoride (PVDF) microporous membrane. Finally, membranes were scanned by a fluorescence imager (Odyssey CLX, LI-COR BiosciencesBiotechnology, Lincoln, NE, USA) to detect bands.
Statistical analysis
Data are expressed as mean ± standard deviation (SD). Statistical differences were evaluated by SPSS 21.0 software (SPSS Inc, USA). Comparison between different groups were performed by one-way analysis of variance (ANOVA). P < 0.05 was considered statistically significant.
RESULTS
Effect of A. anomala extracts on cell viability
The effect of A. anomala extracts on HaCaT cell growth were assessed 12 or 24 h after treatment by MTT assay. The results were presented in Figure 1 , which showed that cell viability was increased in the presence of the extract compared with control. A. anomala extracts treatment for four days increased cell viability by about 3-fold (p < 0.05). The difference increased in a time-dependent manner (P < 0.01). Cells treated with extract for 12 h were slightly less viable than cells treated with the extract for 24 h, but this was not significant (p > 0.05). Thus, extracts of A. anomala promoted viability of HaCaT cells. 
Mechanism of action of A. anomala extracts on HaCaT cells
To further understand the mechanism by which the extract of A. anomala act on HaCaT cells, the key proteins in the MAPK signaling pathway, specifically JNK, ERK, and MAPK were measured in untreated cells or cells treated with extract. First, the mRNA for these proteins with qRT-PCR was quantified. The results were shown in Figure 4 A. The mRNA for ERK, JNK, and p38 MAPK were decreased of 49, 49 and 78 %, respectively, after 24 h of treatment with extract compared with control (p < 0.01).
For western blot assay, treatment of the keratinocytes with A. anomala extracts for 12 and 24 h decreased expression of pro-inflammatory cytokines (Figure 4 B) . There was no detectable difference between cells treated with extract for 12 or 24 h in either mRNA or protein expression of JNK, ERK, and MAPK. Therefore, the addition of extracts of A. anomala suppressed the MAPK signaling pathway in HaCaT cells. 
Cell viability and ROS content of HaCaT cells
Cell viability was reduced relative to the control when the cells were treated with anisomycin alone for 48 h ( Figure 5A ; p < 0.05 on Day 2, p < 0.01 Days 3 and 4). Specifically, it was decreased 17.22 % on Day 2, 35.01 % on Day 3, and 63.18 % on Day 4. When cells were treated with anisomycin and the extract, viability was reduced 31.17% on Day 2, but was greater than Day 4, which was still lower than only A. anomala extracts treatment (31.82 %, p < 0.01).
The ROS content of cells is shown in Figure 5B . The ROS content increased in response to 48 h of anisomycin treatment relative to the control (P < 0.05 on Day 2 and P < 0.01 on Days 3 and 4). It increased 15.04% over the control on Day 2, 27.31 % on Day 3, and 52.25 % on Day 4. When cells were treated with both anisomycin and the extract, the ROS content was enhanced 39.9 % over the control on Day 2, but decreased by Day 4 (P < 0.01). So, treatment with the extract neutralized the effects of MAPK activator, which is consistent with the proposal that the extract acted via the MAPK signaling pathway in the HaCaT cells. 
A. anomala extract inhibited cell apoptosis in HaCaT cells
Previous findings indicate that the A. anomala extract inhibited cell apoptosis in HaCaT cells. To explore the mechanism and evaluate the effect, the extract on key proteins of apoptosis pathways was measured by western blot. The results are shown in Figure 6 . Treatment with the extract for 12 h and 24 h slightly suppressed expression of cleaved caspase-9 protein and markedly inhibited expression of cleaved caspase-8 and cleaved caspase-3 proteins, compared with the control. The ratio of Bcl-2/Bax was enhanced by A. anomala extracts. The extract inactivated the caspase pathways in HaCaT cells. This study provided a foundation for understanding the role of the extract in growth of keratinocytes, as the extract has potential for clinical application in psoriasis therapy. In the past two decades, dramatic advances have been achieved in the discovery and application of plant extracts as sources of natural medicinal products. Many of them have anti-oxidative activity, which has formed the foundation for a variety of applications in pharmaceuticals, alternative medicine, and naturopathy [15, 16] . It has been noted that methanol extracts of A. anomala possessed potent antioxidant and antibacterial features, and might serve as a natural herbal source used in the food and pharmaceutical industries [17] .
The properties of keratinocytes, specifically their growth and antioxidant capability, are important in psoriasis. Moreover, keratinocytes can affect the pathogenesis of psoriasis by interplaying with various innate immune cells, such as dendritic cells and macrophages [18] . Xiong et al noted that the viability of keratinocytes could guide the therapy of psoriasis [12] . The level of ROS was enhanced in lesional and non-lesional skin of psoriasis patients, and the oxidant-antioxidant imbalance was of great significance in psoriasis [18] . In fact, the ROS content of keratinocytes has been used as a marker of oxidative damage in the tissue. As result, extracts of A. anomala act on two critical factors in psoriasis.
Proteins in the MAPK signaling pathway, specifically JNK, ERK, ERK5, and p38 MAPK, are involved in a host of critical cellular processes and activate mitochondrial pathways [19, 20] . It is clear that the ERK signaling pathway regulates cell proliferation, apoptosis, and differentiation [21] [22] [23] . The current study revealed that the phosphorylation of JNK, ERK, and p38MAPK in HaCaT cells were inhibited by treatment with extracts of A. anomala. The results suggest that these extracts aberrantly inactivated the MAPK signaling pathway.
The effect of the extract on the MAPK pathway by examining the effect of an activator of the MAPK pathway, anisomycin, and the extract in tandem was further assessed. If the extract inhibits the MAPK pathway, it should reverse the effects of the activator on cell viability and the accumulation of ROS in the keratinocytes. The experiment was consistent with this prediction, and A. anomala extracts regulating the MAPK signaling pathway in keratinocytes.
To further investigate the mechanism of the extract's inhibitory effect on apoptosis, signaling cascades involving the caspase pathway, specifically caspase-3, caspase-8, caspase-9, Bax, and Bcl-2 were measured [11] . It has been proposed that the activating caspases, caspase-3, -8, and -9, serve as biochemical hallmarks of apoptosis [24] . The extract inactivated the expression of caspase-3 and 8, markedly at 24 h after treatment. A. anomala extracts might affect apoptosis of HaCaT cells by inhibiting the initiation as well as execution of caspase pathways. 
